Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:49 PM
Ignite Modification Date:
2025-12-24 @ 3:49 PM
NCT ID:
NCT00089492
Eligibility Criteria:
Inclusion Criteria:
* HIV-1 infected adults or adolescents \>=16 years of age;
* HIV-1 RNA \>=5000 copies/mL;
* prior experience or documented resistance to each of the 3 currently available classes of ARV drugs (nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, and protease inhibitors).
Exclusion Criteria:
* history of prior use of Fuzeon or T-1249;
* female patients who are pregnant or breastfeeding, or who plan to become pregnant during the study;
* current severe illness;
* currently taking drugs affecting the immune system, HIV vaccine, or investigational agents for any conditions other than HIV/AIDS.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT00089492
Study Brief:
Protocol Section:
NCT00089492